References
- Whisnant JP, Matsumoto N, Ekeback LR. The effect of anticoagulant therapy on the prognosis of patients with transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973: 48(12): 844–8 passim
- Toole JF. Cerebrovascular disorders. 3d ed. New York: Raven Press, 1984
- Whisnant JP, Matsumoto N, Elveback LR. Transient cerebral ischemic attacks in a community: Rochester, Minnesota, 1955 through 1969. Mayo Clin Proc 1973: 48(3): 194–8
- Moran EJ. Stroke therapy advances open new era in care. Hospitals 1990: 64(18): 66–8
- Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. BMJ (Clin Res) 1988: 296(6618): 320–31
- Hass WK, Easton JD, Adams HP Jr, et al. A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. N Engl J Med 1989: 321(8): 501–7
- North American Symptomatic Carotid Endarterectomy Trial (NASCET) Investigators. Clinical alert: benefit of carotid endarterectomy for patients with high-grade stenosis of the internal carotid artery. Stroke 1991: 22(6): 816–7
- European Carotid Surgery Trialists' Collaborative Group. MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70–99%) or with mild (0–29%) carotid stenosis. Lancet 1991: 337(8752): 1235–43
- North American Symptomatic Carotid Endarterectomy Study Group. Carotid endarterectomy: three critical evaluations. (Editorial) Stroke 1987: 18(6): 987–9
- Fields WS, Maslenikov V, Meyer JS, et al. Joint study of extracranial arterial occlusion. V. Progress report of prognosis following surgery or nonsurgical treatment for transient cerebral ischemic attacks and cervical carotid artery lesions. JAMA 1970: 211(12): 1993–2003
- Shaw DA, Venables GS, Cartlidge NE, et al. Carotid endarterectomy in patients with transient cerebral ischaemia. J Neurol Sci 1984: 64(1): 45–53
- American College of Physicians. Indications for carotid endarterectomy. Ann Intern Med 1989: 111(8): 675–7
- Jonas S. Anticoagulant therapy in cerebrovascular disease: review and meta-analysis. Stroke 1988: 19(8): 1043–8 [erratum, Stroke 1989: 20(4): 562]
- Keith DS, Phillips SJ, Whisnant JP, et al. Heparin therapy for recent transient focal cerebral ischemia. Mayo Clin Proc 1987;62(12): 1101–6 [erratum, Mayo Clin Proc 1988: 63(1): 92]
- Putnam SF, Adams HP Jr. Usefulness of heparin in initial management of patients with recent transient ischemic attacks. Arch Neurol 1985: 42(Oct): 960–2
- Biller J, Bruno A, Adams HP Jr, et al. A randomized trial of aspirin or heparin in hospitalized patients with recent transient ischemic attacks: a pilot study. Stroke 1989: 20(4): 441–7
- Warlow C, Morris PJ, eds. Transient ischemic attacks. New York: Marcel Dekker, 1982
- Duke RJ, Bloch RF, Turpie AG, et al. Intravenous heparin for the prevention of stroke progression in acute partial stable stroke: a randomized controlled trial. Ann Intern Med 1986: 105(6): 825–8
- Bousser MG, Eschwege E, Haguenau M, et al. “AICLA” controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke 1983: 14(1): 5–14
- ESPS Group. European Stroke Prevention Study. Stroke 1990: 21(8): 1122–30
- UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. BMJ (Clin Res) 1988: 296(6618): 316–20
- The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978: 299(2): 53–9
- Saltiel E, Ward A. Ticlopidine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in platelet-dependent disease states. Drugs 1987: 34(2): 222–62
- Gent M, Blakely JA, Easton JD, et al. The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke. Lancet 1989: 1(8649): 1215–20